MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluation of the Effect of STN-DBS on the Gastrointestinal Symptoms in Patients with Parkinson’s Disease via GIQLI

A. Yilmaz, E. Okuyucu, M. Ugur (Hatay, Turkey)

Meeting: 2018 International Congress

Abstract Number: 1551

Keywords: Autonomic dysfunction, Deep brain stimulation (DBS), Gastrointestinal problemsm(also see autonomic dysfunction)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: Our aim is to evaluate the effects of Subthalamic Nucleus (STN)-DBS on the quality of life in PD patients by using the Gastrointestinal Quality of Life Index (GIQLI).

Background: Although PD leads to motor symptoms, a lot of patients suffer by a wide range of nonmotor symptoms. Deep Brain Stimulation (DBS) surgery is well established surgical therapy for treating the symptoms of patients with Parkinson’s disease (PD). Several reports claimed that the STN-DBS may led to improvement especially on nonmotor complaints like dyspepsia, constipation, and gastrointestinal motility. We preferred to use GIQLI test for evaluating the GIS complaints and the quality of life in patients that underwent STN-DBS and there are limited number of publications in the literature about this issue.

Methods: 26 patients who underwent STN-DBS because of PD were included in this study. The patients were evaluated before surgery and 3 months after surgery by GIQLI test. The medications history were compared too.

Results: When the preoperatif mean GIQLI score was 84.48±6.19, postoperative mean GIQLI score was found as122.89±3.34 (Table-1). The difference between the preoperative and postoperative results, was statistically significance. Also after the DBS surgery the number of patients who needs medications for the gastrointestinal system (GIS) complaints were found decreased significantly.

Conclusions: STN-DBS leads to improve the quality of life in PD patients especially by reducing the GIS complaints.

References: 1. Fasano A, Daniele A, Albanese A. Treatment of motor and non-motor features of Parkinson’s disease with deep brain stimulation. Lancet Neurol. 2012; 11(5): 429-42. 2. Prakash KM, Nadkarni NV, Lye WK, Yong MH, Tan EK. The impact of non-motor symptoms on the quality of life of Parkinson’s disease patients: a longitudinal study. Eur J Neurol. 2016; 23(5): 854-60.

To cite this abstract in AMA style:

A. Yilmaz, E. Okuyucu, M. Ugur. Evaluation of the Effect of STN-DBS on the Gastrointestinal Symptoms in Patients with Parkinson’s Disease via GIQLI [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/evaluation-of-the-effect-of-stn-dbs-on-the-gastrointestinal-symptoms-in-patients-with-parkinsons-disease-via-giqli/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluation-of-the-effect-of-stn-dbs-on-the-gastrointestinal-symptoms-in-patients-with-parkinsons-disease-via-giqli/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley